Literature DB >> 8839779

Role of the T cell receptor alpha-chain in superantigen recognition.

M A Blackman1, D L Woodland.   

Abstract

Superantigens bind to antigen-presenting cells on the outside of the major histocompatibility complex (MHC) class II molecule and to T cells via the external face of the T cell receptor (TCR) V beta element. As a consequence, superantigens stimulate populations of T cells in a V beta-specific, non-MHC-restricted manner. However, accumulating evidence has shown an additional contribution of the TCR alpha-chain and polymorphic residues of the MHC molecule to superantigen recognition by some T cells. These data suggest that the TCR and MHC come into contact during superantigen engagement and indirectly modulate the superantigen reactivity. Thus, additional interactions between non-V beta elements of the TCR and MHC play a role in the overall stability of the superantigen/MHC/TCR complex, explaining the influence of the TCR alpha-chain. It is likely that this additional interaction is of greater consequence for weakly reactive T cells. This modulation of superantigen reactivity in individual T cells may have physiological consequences, for example, in the induction of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8839779     DOI: 10.1007/bf02918500

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  84 in total

1.  Crystal structure of staphylococcal enterotoxin B, a superantigen.

Authors:  S Swaminathan; W Furey; J Pletcher; M Sax
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

2.  T-cell antigen receptor binding sites for the microbial superantigen staphylococcal enterotoxin A.

Authors:  C H Pontzer; M J Irwin; N R Gascoigne; H M Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

3.  Activation requirements of cloned inducer T cells. III. Need for two stimulator cells in the response of a cloned line to Mls determinants.

Authors:  R H DeKruyff; S T Ju; J Laning; H Cantor; M E Dorf
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

4.  The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens.

Authors:  A M Pullen; P Marrack; J W Kappler
Journal:  Nature       Date:  1988-10-27       Impact factor: 49.962

Review 5.  In vivo effects of superantigens.

Authors:  M A Blackman; D L Woodland
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

6.  Stimulation of B10.BR T cells with superantigenic staphylococcal toxins.

Authors:  J E Callahan; A Herman; J W Kappler; P Marrack
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

7.  T cell receptor alpha-chain influences reactivity to Mls-1 in V beta 8.1 transgenic mice.

Authors:  H P Smith; P Le; D L Woodland; M A Blackman
Journal:  J Immunol       Date:  1992-08-01       Impact factor: 5.422

8.  T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.

Authors:  E W Ehrich; B Devaux; E P Rock; J L Jorgensen; M M Davis; Y H Chien
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

9.  HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells.

Authors:  A Herman; G Croteau; R P Sekaly; J Kappler; P Marrack
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

10.  Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells.

Authors:  R Wen; G A Cole; S Surman; M A Blackman; D L Woodland
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  1 in total

1.  Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen?

Authors:  R A Tripp; A M Hamilton-Easton; R D Cardin; P Nguyen; F G Behm; D L Woodland; P C Doherty; M A Blackman
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.